Stryker scoops up Scopis

Scopis, a Germany-based surgical guidance device spinout of the Fraunhofer Institute for Production Channels and Design Engineering (IPK) and university hospital Charité–Universitätsmedizin Berlin, has been acquired by medical technology supplier Stryker for an undisclosed sum.
The deal was officially announced today by Fraunhofer Society, but was actually completed in November 2017. Charité–Universitätsmedizin Berlin is a medical faculty affiliate to both Humboldt University of Berlin and Free University of Berlin.
Founded in 2010, Scopis has developed a guidance system for endoscopy and microscopy-driven surgical procedures such as neurosurgery, corrective jaw surgery and ear, nose and throat surgery.
Dubbed Scopis Hybrid Navigation, the technology collects optical and electromagnetic feedback from the body via an attachable surgical unit, with the feedback serving as the basis for guidance delivered via the device’s augmented reality-enabled display.
Stryker expects Scopis’s product to benefit from its status as an international company through opportunities for operational synergies and scale.
Scopis closed a series A round of undisclosed size in 2013 that featured Fraunhofer Society, the association of German applied research institutes including Fraunhofer IPK.
IBB Beteiligungsgesellschaft, the venture arm of state development bank Investitionsbank Berlin, also backed the series A together with family office Falk Strascheg Holding and public-private partnership High-Tech Gründerfonds (HTGF), the latter of which had put up an undisclosed seed sum for Scopis three years before.
Fraunhofer Society was identified as an existing investor at the time of the series A round, though details of its earlier involvement could not be ascertained.
Scopis was co-founded by its chief executive Bartosz Kosmecki, a former researcher at Fraunhofer and Charité–Universitätsmedizin Berlin, together with his former research colleague Andreas Reutter.